Risk factors for resignation from work after starting infertility treatment among Japanese women: Japan-Female Employment and Mental health in Assisted reproductive technology (J-FEMA) study

ObjectiveTo elucidate the risk factors associated with resignation from work of Japanese women undergoing infertility treatment.MethodsA total of 1727 female patients who attended a private fertility clinic in Japan participated in the Japan-Female Employment and Mental health in Assisted reproductive technology study. Questions related to demographic, clinical and socioeconomic characteristics were employed in the questionnaire. Out of the 1727 patients, 1075 patients who were working at the time of initiating infertility treatment and felt infertility treatment incompatible with work were included in the analysis. Risk factors for resignation were assessed by using multivariable logistic regression models.ResultsAmong 1075 working women who started infertility treatment, 179 (16.7%) subsequently resigned. Multivariable-adjusted ORs for resignation in those with lower educational background and infertility for ≥2 years were 1.58 (95% CI: 1.07 to 2.34) and 1.82 (95% CI: 1.15 to 2.89), respectively. The OR for resignation in non-permanent workers undergoing infertility treatment was 2.65 (95% CI: 1.61 to 4.37). While experiencing harassment in the workplace approached significance, lack of support from the company was significantly associated with resignation after starting infertility treatment, with ORs of 1.71 (95% CI: 0.98 to 2.99) and 1.91 (95% CI: 1.28 to 2.86), respectively.ConclusionOne-sixth of women resigned after starting infertility treatments. It was found that factors related to education, infertility duration and work environment were significantly associated with resignation. Reducing the physical and psychological burden endured by women, for example, by increasing employer-provided support, is vitally important in balancing infertility treatment with maintenance of work life.

Download Full-text

Analysis of severe psychological stressors in women during fertility treatment: Japan-Female Employment and Mental health in Assisted reproductive technology (J-FEMA) study

Archives of Gynecology and Obstetrics ◽

10.1007/s00404-020-05923-6 ◽

2021 ◽

Author(s):

Yuko Ikemoto ◽

Keiji Kuroda ◽

Motoki Endo ◽

Atsushi Tanaka ◽

Rikikazu Sugiyama ◽

...

Keyword(s):

Mental Health ◽

Assisted Reproductive Technology ◽

Reproductive Technology ◽

Female Employment ◽

Fertility Treatment ◽

Psychological Stressors

Download Full-text

Gestagens in assisted reproductive technology programs

GYNECOLOGY ◽

10.26442/20795696.2019.2.190238 ◽

2019 ◽

Vol 21 (2) ◽

pp. 76-79

Author(s):

Anastasia G Syrkasheva ◽

Yana A Petrosyan ◽

Natalia V Dolgushina

Keyword(s):

Assisted Reproductive Technology ◽

Luteal Phase ◽

Ovarian Hyperstimulation Syndrome ◽

Infertility Treatment ◽

Reproductive Technology ◽

Art Programs ◽

Drug Effectiveness ◽

Essential Step ◽

Endogenous Steroid ◽

Endogenous Steroid Hormones

Background. Luteal phase (LP) drug support is an important step in assisted reproductive technology (ART) programs efficacy. Aim. To present up-to-date data on an efficacy of LP hormonal support during ART cycles as well as to conduct a comparative analysis of various gestagen drug effectiveness. Materials and methods. To write this review domestic and foreign publications were searched in Russian and international search systems (PubMed, eLibrary, etc.) for the last 8 years. The review includs articles from peer-reviewed literature. Results. LP drug support becomes an essential step in infertility treatment in various ART programs. Although human chorionic gonadotropin drug injections in the posttransfer period leads to an activation of endogenous steroid hormones synthesis, exogenous hormones use is currently preferred because of not having a risk of ovarian hyperstimulation syndrome. Conclusions. The variety of progesterone drugs is accompanied by a lack of algorithms for their use in various clinical situations. Further studies are required to evaluate progesterone drugs efficacy for various subgroups of patients.

Download Full-text

Hope and anxiety: The study of female embodied experience with assisted reproductive technology

Chinese Journal of Sociology ◽

10.1177/2057150x211002982 ◽

2021 ◽

Vol 7 (2) ◽

pp. 138-170

Author(s):

Chengpu Yu ◽

Wanlin Li ◽

Mingfen Deng

Keyword(s):

Assisted Reproductive Technology ◽

Social Factors ◽

Cultural Context ◽

Infertility Treatment ◽

Reproductive Technology ◽

The Body ◽

Local Culture ◽

Embodied Experience ◽

Experiences Of Women ◽

Infertile Patients

Assisted reproductive technology (ART) is hailed as “the holy grail” for infertile patients in the mainstream narrative. The existing studies have clearly demonstrated how external social factors shape how ART is to be used, but they ignore the recipients of the technologies, and especially the experiences of women. Based on an investigation conducted in Z hospital’s reproductive center, this article regards embodiment as the methodological orientation for integrating socio-cultural context with female embodied experience in order to show their bio-social entanglement. As fieldwork evidence indicates, ART in practice is far from simple “hope technology”; instead, it throws women into a paradoxical world in which hope and anxiety coexist. Embodied experience, hope, and anxiety are transmitted through the bodies of women, which reveals the inscription of social-cultural context and technical uncertainty on the female body and, meanwhile, women actively learn strategies by which to cope with the technical uncertainty and moral pressures from local culture (including healing the body, folk religion, etc.), so as to hold onto infertility treatment with hope.

Download Full-text